| Name | Title | Contact Details |
|---|
Dayspring Services of Arkansas is a Springdale, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
High-performing pharmacy is who we are At Visante, we believe in moving healthcare forward through innovative solutions that deliver lasting results. For over 20 years, we`ve been advancing the business of pharmacy™ by helping our clients deliver compliant services and products that foster growth and improve patient care. Our firm focuses on three areas of medication management: hospitals and health systems, pharmaceutical industry and managed care/government programs. Integrated health networks (IDNs), hospitals and health systems know us for our expertise to maximize lasting growth in 340B programs, specialty pharmacy, pharmacy assessments, sterile compounding and drug diversion. In addition, through our partner PharmacyStars, we provide a platform of technology solutions for our hospital and health system clients to maximize compliance in the areas of 340B, sterile compounding, drug diversion and more. Our managed care and government programs experts are here to help you navigate complex, changing requirements to reach compliance goals. Specializing in Medicare Parts C and D consulting, we can help you prepare for audits by the Centers for Medicare and Medicaid Services (CMS), conduct mock audits, improve operations, and maintain compliance. No matter how complex your compliance issues and operational needs are, we`re here to implement quality, cost-effective solutions. Visante consists of more than 60 consultants across the U.S., Canada, and the U.K., all working together to provide expert guidance from a wide range of disciplines, including pharmacy, nursing, operations, and information technology. We`re here to move the practice of pharmacy in the right direction.
NurseCore Management is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Elite Research Network, LLC is a Mount Pleasant, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.